Implantable Drug Delivery Systems (IDDS) After Failure of Comprehensive Medical Management (CMM) Can Palliate Symptoms in the Most Refractory Cancer Pain Patients-Reference-Cited by-同舟云学术

Implantable Drug Delivery Systems (IDDS) After Failure of Comprehensive Medical Management (CMM) Can Palliate Symptoms in the Most Refractory Cancer Pain Patients

Published:2005-08 Issue:4 Volume:8 Page:736-742
ISSN:1096-6218
Container-title:Journal of Palliative Medicine
language:en
Short-container-title:Journal of Palliative Medicine

Author:

Smith Thomas J.¹,Coyne Patrick J.¹

Affiliation:

1. Thomas Palliative Care Unit, Virginia Commonwealth University, Richmond, Virginia.

Publisher

Mary Ann Liebert Inc

Subject

Anesthesiology and Pain Medicine,General Medicine,General Nursing

Link

http://www.liebertpub.com/doi/pdf/10.1089/jpm.2005.8.736

Reference10 articles.

1. Randomized Clinical Trial of an Implantable Drug Delivery System Compared With Comprehensive Medical Management for Refractory Cancer Pain: Impact on Pain, Drug-Related Toxicity, and Survival

2. What Is the Evidence for Implantable Drug Delivery Systems for Refractory Cancer Pain?

3. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function

4. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology

5. Implementing Guidelines for Cancer Pain Management: Results of a Randomized Controlled Clinical Trial

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society’s recommendations for best clinical practice;British Journal of Pain;2024-09-07

2. Intrathecal drug delivery systems for cancer pain: A retrospective analysis at a single tertiary medical center in China;Heliyon;2024-07

3. Implanted intrathecal drug delivery systems may be associated with improved survival in patients with cancer;British Journal of Pain;2023-10-16

4. More time in a community setting: A service evaluation of the impact of intrathecal drug delivery systems on place of care of patients with cancer pain;Palliative Medicine;2023-08-26

5. Minimally invasive interventional therapy for pain;Journal of Interventional Medicine;2023-05